bisbenzimidazole and u 0126

bisbenzimidazole has been researched along with u 0126 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavanaugh, J; Chopra, I; Flaherty, PT; Jain, P; Monlish, D1
Cui, C; Ding, HF; Fan, Y; Fu, SB; Jiang, LH; Li, J; Ma, L; Sun, DJ; Yang, J; Zhang, YN1

Other Studies

2 other study(ies) available for bisbenzimidazole and u 0126

ArticleYear
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
    Bioorganic & medicinal chemistry, 2010, Nov-15, Volume: 18, Issue:22

    Topics: Benzimidazoles; Epidermal Growth Factor; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Structure-Activity Relationship

2010
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
    Die Pharmazie, 2012, Volume: 67, Issue:8

    Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf

2012